PolTREG S.A. Cash Flow Conversion Efficiency
PolTREG S.A. cash flow conversion efficiency. Based on the latest financial reports, PolTREG S.A. (PTG) has a cash flow conversion efficiency ratio of -0.154x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-7.63 Million ≈ $-2.10 Million USD) by net assets (zł49.48 Million ≈ $13.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of PolTREG S.A. (2018–2024)
Cash flow conversion efficiency of PolTREG S.A. from 2018 to 2024. This chart illustrates how PolTREG S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View PolTREG S.A. (PTG) stock price for real-time trading data and today's change.
PolTREG S.A. Cash Flow Conversion Ratio Explained
PolTREG S.A. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
PolTREG S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PolTREG S.A. ranked by their cash flow conversion efficiency. Also see market cap of PolTREG S.A. for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hyrican Informationssysteme Aktiengesellschaft
F:HYI
|
N/A |
|
De.Mem Ltd
AU:DEM
|
0.064x |
|
Q-Gold Resources Ltd
V:QGR
|
0.311x |
|
Fortune Bay Corp
V:FOR
|
0.008x |
|
Vietnam Petroleum Transport JSC
VN:VIP
|
-0.030x |
|
QPM Energy Ltd
AU:QPM
|
-0.108x |
|
Emdeki Utama Tbk PT
JK:MDKI
|
0.013x |
|
Laurion Mineral Exploration Inc
V:LME
|
-0.278x |
Annual Cash Flow Conversion Efficiency for PolTREG S.A. (2018–2024)
The table below shows the annual cash flow conversion efficiency of PolTREG S.A. from 2018 to 2024. Review PolTREG S.A. free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | zł69.23 Million ≈ $19.05 Million |
zł-16.00 Million ≈ $-4.40 Million |
-0.231x | -52.30% |
| 2023-12-31 | zł87.52 Million ≈ $24.09 Million |
zł-13.28 Million ≈ $-3.66 Million |
-0.152x | -78.29% |
| 2022-12-31 | zł101.04 Million ≈ $27.81 Million |
zł-8.60 Million ≈ $-2.37 Million |
-0.085x | -128.55% |
| 2021-12-31 | zł103.01 Million ≈ $28.35 Million |
zł-3.84 Million ≈ $-1.06 Million |
-0.037x | +82.85% |
| 2020-12-31 | zł12.83 Million ≈ $3.53 Million |
zł-2.79 Million ≈ $-767.30K |
-0.217x | -100.11% |
| 2019-12-31 | zł-6.00K ≈ $-1.65K |
zł-1.19 Million ≈ $-327.51K |
198.333x | +14627.96% |
| 2018-12-31 | zł764.00K ≈ $210.26K |
zł-1.04 Million ≈ $-287.05K |
-1.365x | -- |
About PolTREG S.A.
Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, as well as multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland.